研究论文

含咔唑/苯并咪唑环的2,5-二取代-1,3,4-噻二唑酰胺衍生物的合成及对PTP1B/TCPTP抑制活性的评价

  • 李英俊 ,
  • 赵月 ,
  • 靳焜 ,
  • 高立信 ,
  • 盛丽 ,
  • 刘雪洁 ,
  • 杨鸿境 ,
  • 林乐弟 ,
  • 李佳
展开
  • a 辽宁师范大学化学化工学院 大连 116029;
    b 大连理工大学精细化工国家重点实验室 大连 116012;
    c 中国科学院上海药物研究所 国家新药筛选中心 药物研究国家重点实验室 上海 201203

收稿日期: 2019-01-10

  修回日期: 2019-04-12

  网络出版日期: 2019-04-16

基金资助

辽宁省自然科学基金(No.20102126)资助项目.

Synthesis and PTP1B/TCPTP Inhibitory Activity Evaluation of Novel 2,5-Disubstituted-1,3,4-thiadiazolamide Derivatives Containing Carbazole/Benzimidazole Moity

  • Li Yingjun ,
  • Zhao Yue ,
  • Jin Kun ,
  • Gao Lixin ,
  • Sheng Li ,
  • Liu Xuejie ,
  • Yang Hongjing ,
  • Lin Ledi ,
  • Li Jia
Expand
  • a College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029;
    b State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116012;
    c National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203

Received date: 2019-01-10

  Revised date: 2019-04-12

  Online published: 2019-04-16

Supported by

Project supported by the Natural Science Foundation of Liaoning Province (No. 20102126).

摘要

合成了一系列新型含咔唑/苯并咪唑环的2,5-二取代-1,3,4-噻二唑酰胺衍生物.利用IR,1H NMR,13C NMR和元素分析对其进行了结构表征.评价了目标化合物对蛋白酪氨酸磷酸酶1B(PTP1B)和T细胞蛋白酪氨酸磷酸酶(TCPTP)的抑制活性,讨论了结构与活性的关系.实验结果显示,绝大多数化合物对PTP1B的抑制活性超过高度同源的TCPTP的抑制活性,其中2-(9-咔唑基亚甲基)-5-(3-氯苯甲酰氨基)-1,3,4-噻二唑(5c)对PTP1B的抑制活性最高[IC50=(2.43±0.43)μg/mL],2-(9-咔唑基亚甲基)-5-(4-甲基苯甲酰氨基)-1,3,4-噻二唑(5b)和化合物5c对PTP1B的抑制活性均高于阳性对照药物齐墩果酸.对目标化合物5c进行分子对接研究和密度泛函理论(DFT)计算.分子对接结果表明,5c与PTP1B酶通过形成氢键、疏水和π-π等相互作用形成稳定的复合物.

本文引用格式

李英俊 , 赵月 , 靳焜 , 高立信 , 盛丽 , 刘雪洁 , 杨鸿境 , 林乐弟 , 李佳 . 含咔唑/苯并咪唑环的2,5-二取代-1,3,4-噻二唑酰胺衍生物的合成及对PTP1B/TCPTP抑制活性的评价[J]. 有机化学, 2019 , 39(9) : 2599 -2608 . DOI: 10.6023/cjoc201901013

Abstract

A series of novel 2,5-disubstituted-1,3,4-thiadiazolamide derivatives containing carbazole/benzimidazole moity were synthesized. Their structures were characterized by IR, 1H NMR, 13C NMR spectra and elemental analysis. All synthesized target compounds were evaluated for the inhibitory activities against protein tyrosine phosphatase 1B (PTP1B) and T-cell protein tyrosine phosphatase (TCPTP). The structure-activity relationship was discussed. The results showed that most of compounds had good inhibitory activity against PTP1B over the highly homologous TCPTP, and 2-(9-carbazolylmethylene)-5-(3-chlorobenzoylamino)-1,3,4-thiadiazole (5c) displayed the highest inhibitory activity against PTP1B[IC50=(2.43±0.43) μg/mL]. The inhibitory activities of 2-(9-carbazolylmethylene)-5-(4-methylbenzoylamino)-1,3,4-thiadiazole (5b) and 5c against PTP1B were higher than that of positive control oleanolic acid. Molecular docking and density functional theory (DFT) calculations of the target compound 5c were performed. The docking result showed that compound 5c and PTP1B enzyme formed a stable complex by hydrogen bonds, hydrophobic and π-π interactions.

参考文献

[1] Lima, R. C. L.; Kato, L.; Kongstad, K. T.; Staerk, D. J. Funct. Foods 2018, 45, 444.
[2] Costa, F. N.; Ibiapino, A. L.; Figueiredo, L. P.; Barreiro, E. J.; Lima, L. M.; Amaral, D. N.; Castro, C. E.; Giacomelli, F. C.; Ferreira, F. F. J. Phys.:Conf. Ser. 2015, 617, 012015.
[3] Dong. S. Z.; Lei, Y. B.; Jia, S. K.; Gao, L. X.; Li, J.; Zhu, T.; Liu, S. Y.; Hu, W. H. Bioorg. Med. Chem. Lett. 2017, 27, 1105.
[4] Kostrzewa, T.; Sahu, K. K.; Ponikowska, M. G.; Tuszynski, J. A.; Jankowska, A. K. Drug Des., Dev. Ther. 2018, 12, 4139.
[5] He, R. J.; Yu, Z. H.; Zhang, R. Y.; Zhang, Z. Y. Acta Pharmacol. Sin. 2014, 35, 1227.
[6] Galic, S.; Hauser, C.; Kahn, B. B.; Haj, F. G.; Neel, B. G.; Tonks, N. K.; Tiganis, T. Mol. Cell. Biol. 2005, 25, 819.
[7] Du, Y. L.; Zhang, Y. H.; Ling, H.; Li, Q. Y.; Shen, J. K. Eur. J. Med. Chem. 2018, 144, 692.
[8] Mougenot, P.; Namane, C.; Fett, E.; Camy, F.; Dadji-Faïhun, R.; Langot, G.; Monseau, C.; Onofri, B.; Pacquet, F.; Pascal, C.; Crespin, O.; Ben-Hassine, M.; Ragot, J. L.; Van-Pham, T.; Philippo, C.; Chatelain-Egger, F.; Péron, P.; Bail, J. C. L.; Guillot, E.; Chamiot-Clerc, P.; Chabanaud, M. A.; Pruniaux, M. P.; Schmidt, F.; Venier, O.; Nicolaï, E.; Viviani, F. Bioorg. Med. Chem. Lett. 2012, 22, 2497.
[9] Li, Y. J.; Yu, Y.; Jin, K.; Gao, L. X.; Luo, T. C.; Sheng, L.; Shao, X.; Li, J. Bioorg. Med. Chem. Lett. 2014, 24, 4125.
[10] Li, L.; Meng, Y.; Li, Z. Y.; Dai, W. H.; Xu, Xi.; Bi, X. L.; Bian, J. L. Eur. J. Med. Chem. 2019, 163, 215.
[11] Xu, X.; Meng, Y.; Li, L.; Xu, P. F.; Wang, J. B.; Li, Z. Y.; Bian, J. L. J. Med. Chem. 2018, 62, 1096.
[12] Kulshreshtha, A.; Piplani, P. Eur. J. Med. Chem. 2016, 122, 557.
[13] Lee, E. C. Y.; Futatsugi, K.; Arcari, J. T.; Bahnck, K.; Coffey, S. B.; Derksen, D. R.; Kalgutkar, A. S.; Loria, P. M.; Sharma, R. Bioorg. Med. Chem. Lett. 2016, 26, 2670.
[14] Jakovljevi?, K.; Mati?, I. Z.; Stanojkovi?, T.; Krivoku?a, A.; Markovi?, V.; Joksovi?, M. D.; Mihailovi?, N.; Ni?iforovi?, M.; Joksovi?, L. Bioorg. Med. Chem. Lett. 2017, 27, 3709.
[15] Gao, Y. Q.; Li, J.; Song, Z. Q.; Song, J.; Shang, S. B.; Xiao, G. M.; Wang, Z. D.; Rao, X. P. Ind. Crops Prod. 2015, 76, 660.
[16] Li, Y.-J.; Wang, S.-Y.; Jin, K.; Gao, L.-X.; Sheng, L.; Zhang, N.; Liu, J.-H.; Li, J. Chin. J. Org. Chem. 2019, 39, 491(in Chinese). (李英俊, 王思远, 靳焜, 高立信, 盛丽, 张楠, 刘继红, 李佳, 有机化学, 2019, 39, 491.)
[17] Salih, N.; Salimon, J.; Yousif, E. Arabian J. Chem. 2016, 9, S781.
[18] Aboul-Enein, H. Y.; El Rashedy, A. A. Med. Chem. 2015, 5, 318.
[19] George, M.; Joseph, L.; Kumar, U. Int. J. Curr. Res. Chem. Pharm. Sci. 2017, 4, 38.
[20] Akhtar, W.; Khan, M. F.; Verma, G.; Shaquiquzzaman, M.; Rizvi, M. A.; Mehdi, S. H.; Akhter, M.; Alam, M. M. Eur. J. Med. Chem. 2017, 126, 705.
[21] Özil, M.; Emirik, M.; Etlik, S. Y.; Ülker, S.; Kahveci, B. Bioorg. Chem. 2016, 68, 226.
[22] Rashid, M.; Husain, A.; Mishra, R.; Karim, S.; Khan, S.; Ahmad, M.; Al-wabel, N.; Husain, A.; Ahmad, A.; Khan, S. A. Arabian J. Chem. 2015, DOI:org/101016/j.rabjc.2015.08.019.
[23] Shah, P. B, Darji, N.; Patel, B. Int. J. Inst. Pharma. Life Sci. 2012, 2, 2249.
[24] Abdel-Rahman, T. M. Phosphorus, Sulfur Silicon Relat. Elem. 2006, 181, 1737.
[25] Redayan, M. A.; Ali, W. B.; Mohammed, A. M. Orient. J. Chem. 2017, 33, 3138.
[26] Kaplanc?kl?, Z. A. Marmara Pharm. J. 2011, 15, 105.
[27] Khan, I.; Tantray, M. A.; Hamid, H.; Alam, M. S.; Kalam, A.; Dhulap, A. Bioorg. Med. Chem. Lett. 2016, 26, 4020.
[28] Kaur, H.; Kumar, S.; Vishwakarma, P.; Sharma, M.; Saxena, K. K.; Kumar, A. Eur. J. Med. Chem. 2010, 45, 2777.
[29] Ku?, C.; Ayhan-K?lc?gil, G.; Özbey, S.; Kaynak, F. B.; Kaya, M.; Çoban, T.; Can-Eke, B. Bioorg. Med. Chem. 2008, 16, 4294.
[30] Li, Y.-J.; Wang, S.-Y.; Jin, K.; Gao, L.-X.; Sheng, L.; Zhang, N.; Yang, K.-D.; Zhao, Y.; Li, J. Chin. J. Org. Chem. 2018, 38, 1242(in Chinese). (李英俊, 王思远, 靳焜, 高立信, 盛丽, 张楠, 杨凯栋, 赵月, 李佳, 有机化学, 2018, 38, 1242.)
[31] Li, Y.-J.; Li, J.-Y.; Peng, L.-N.; Gao, L.-X.; Jin, K.; Sheng, L.; Zhang, N.; Wang, S.-Y.; Li, J. Chin. J. Org. Chem. 2017, 37, 485(in Chinese). (李英俊, 李继阳, 彭立娜, 高立信, 靳焜, 盛丽, 张楠, 王思远, 李佳, 有机化学, 2017, 37, 485.)
[32] Li, Y.-J.; Sun, Y.-Z.; Jin, K.; Xu, Y.-T.; Sun, S.-Q. Chin. J. Org. Chem. 2008, 28, 1074(in Chinese). (李英俊, 孙亚珍, 靳焜, 许永廷, 孙淑琴, 有机化学, 2008, 28, 1074.)
[33] Tiganis, T. FEBS J. 2013, 280, 445.
[34] Li, Y.-J.; Yu, Y.; Jin, K.; Gao, L.-X.; Luo, T.-C.; Sheng, L.; Sao, X.; Li, J. Chin. J. Org. Chem. 2015, 35, 129(in Chinese). (李英俊, 于洋, 靳焜, 高立信, 罗潼川, 盛丽, 邵昕, 李佳, 有机化学, 2015, 35, 129.)
[35] Zhang, X. J.; Tian, Y. P.; Li, S. L.; Jiang, M. H.; Usman, A.; Chantrapromma, S.; Fun, H. K. Polyhedron 2003, 22, 397.
[36] Lamani, R. S.; Shetty, N. S.; Kamble, R. R.; Khazi, I. A. M. Eur. J. Med. Chem. 2009, 44, 2828.
[37] Wei, T.-B.; Chen, J.-C.; Wang, X.-C.; Yang, S.-Y. Chem. J. Chin. Univ. 1992, 13, 1217(in Chinese). (魏太保, 陈继畴, 王秀春, 杨素铀, 高等学校化学学报, 1992, 13, 1217.)
[38] Sun, L. P.; Shen, Q.; Piao, H. H.; Ma, W. P.; Gao, L. X.; Zhang, W.; Nan, F. J.; Li, J.; Piao, H. R. Eur. J. Med. Chem. 2011, 46, 3630.

文章导航

/